Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

OncoCyte Corporation OCX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$8.00
+150%

OCX Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value

No ownership data available for OCX.

People Also View

SHC
SHC
Sotera Health Company
$16.03
+0.63%
 OLK
OLK
Olink Holding AB (publ)
$26.08
+0.31%
 CSTL
CSTL
Castle Biosciences, Inc.
$24.62
+1.03%
 PSNL
PSNL
Personalis, Inc.
$6.63
-0.75%
 GTH
GTH
Genetron Holdings Limited
$4.03
+0.12%
 FONR
FONR
FONAR Corporation
$18.77
+0.05%
 STIM
STIM
Neuronetics, Inc.
$1.39
-2.80%
 BDSX
BDSX
Biodesix, Inc.
$12.66
+4.28%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message